Skip to content
Solar Gamble Daily

The Zimbabwean Government Rejects ‘One-Sided’ US Healthcare Assistance Agreement Because of Information Fears

Health funding illustration
The proposed American financial assistance would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) spanning five years due to Washington's demand for sensitive biological samples.

This rejection was revealed after a official document dated December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "skewed".

A government spokesperson later clarified that the United States was seeking biological samples for research and commercial purposes but was not willing to guarantee the benefits from any future treatments.

"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for continued talks to secure a agreement acceptable to both sides so the nation's vital HIV programme can be sustained.

Broader Context

This rejection follows a comparable case in neighbouring Kenya, where a court halted a similar health funding agreement after legal challenges were raised about the security of citizens' health data.

After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had overseen aid for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance openness and responsibility.

Based on statements, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn in committed funds.

Details of the Declined Deal

The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," the Ambassador added.

However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".

"Zimbabwe was being asked to share its biological resources and data over an extended period, with no corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.

"In essence, our country would supply the raw materials for medical research without any assurance that the resulting innovations would be available to our citizens should a new disease outbreak arise."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending structures already set up through the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.

"This mechanism is intended to guarantee that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."

These objections over the US deal "are not meant as hostility towards the US," he added.

"We are open to further dialogue with our US partners on how future co-operation might be designed in a way that honours the sovereignty and interests of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that negotiations must proceed considering much of the nation's Aids initiatives relied on international support.

"If technical issues exist, such as those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group commented.

The situation emphasises the complex challenges between receiving crucial foreign assistance and safeguarding a country's data in an increasingly data-driven world.

The writer

Tracy Bauer

Renewable energy journalist with a decade of experience covering solar innovations and sustainable finance.

Solar Gamble Daily

Type to search articles.